|
Match
|
Document |
Document Title |
|
|
7618951 |
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in...
|
|
|
7618648 |
Satiety inducing composition
The invention provides the use of a whey protein and/or whey protein hydrolysate which stimulate the cellular release of the satiety peptides choleocystokinin and glucagon-like-peptide in the...
|
|
|
7615235 |
Film-shaped or wafer-shaped pharmaceutical preparation with masked taste
The invention relates to thin film-shaped or wafer-shaped pharmaceutical preparations for oral administration of active substances. The preparations contain at least one matrix-forming polymer...
|
|
|
7615207 |
Methods for treating irritable bowel syndrome
Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood...
|
|
|
7608436 |
Process for producing saccharide oligomers
A process for preparing saccharide oligomers uses an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and has a solids concentration of at least...
|
|
|
7608245 |
Methods for manipulating satiety
Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood...
|
|
|
7601364 |
Carbohydrate mixtures
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate...
|
|
|
7597909 |
Dietary supplement containing alkaline electrolyte buffers
An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would...
|
|
|
7597904 |
Metalloproteinase inhibitory agent
The present invention relates to an active agent, in particular a metalloproteinase inhibitory agent of casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria. The...
|
|
|
7595065 |
Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils
An oral composition for oral cleansing, breath freshening, and anti-microbial benefits includes an oral cavity delivery agent and an antimicrobial active agent including a synergistic combination...
|
|
|
7585522 |
Oral immunology using plant product containing a non-enteric pathogen antigen
A method for obtaining an immune response to a non-enteric pathogen antigen (NEPA) such as hepatitis B surface antigen (HBsAg) by feeding the antigen in a plant material to an animal that is...
|
|
|
7575768 |
Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols
A nutritional supplement, prepared food product, or direct food additive for ingestion by mammals, and methods for preparing such products, are provided. Products of the invention comprise an...
|
|
|
7572474 |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and...
|
|
|
7544377 |
Chewable compositions with fast release magnolia bark extract
A chewable oral composition for oral cleansing, breath freshening, and antimicrobial benefits includes fast release Magnolia Bark Extract in combination with a surface active agent. The...
|
|
|
7538137 |
1-O-β-D-glucopyranosylgeraniol-10,5-olide and use thereof
A novel natural compound having various therapeutically effects is provided. The compound is obtainable from Sibiraea leaves by aqueous extraction and is represented by a formula (1) as follows.
|
|
|
7534450 |
Nutrient supplements and methods for treating autism and for preventing the onset of autism
Provided by the present invention are novel and non-obvious nutrient supplements that preferably comprise minerals, vitamins, amino acids, and agents capable of delivering cysteine in vivo. The...
|
|
|
7527805 |
Methods of increasing productivity in older sows while decreasing feed intake
The present invention provides methods for feeding older sows that beneficially reduce feed intake in older sows.
|
|
|
7514472 |
Fat or oil composition
Described is a fat or oil composition which comprises at least 35 wt % of a diacylglycerol, the constituent fatty acids of said diacylglycerol satisfying the following equation: (an amount of a...
|
|
|
7514244 |
Lipid and food compositions containing docosahexaenoic acid and docosapentaenoic acid
A process for preparing lipids which contain docosahexaenoic acid (DHA) and/or docosapentaenoic acid (DPA) is disclosed. The process includes the steps of cultivating in a medium a microorganism...
|
|
|
7514096 |
Triacylglycerols of enriched CLA content
Novel acylglycerides are disclosed comprising mono-, di- and triacylglycerides characterized by predominantly containing the conjugated linoleic acids t9,c11- and c10,t12 octadecadienoic acids to...
|
|
|
7511173 |
Creatine salt with enhanced nutritional and therapeutic efficacy and compositions containing same
The novel salt creatine glycinate and compositions (dietary supplements, energy drinks, and dietetic or pharmaceutical products containing the same are described.
|
|
|
7510721 |
Multi-purpose acid compositions
The invention relates to solutions containing acidic compositions that have a pH of less than 1, are non-caustic to human tissue and are safe for human ingestion. These compositions may be used as...
|
|
|
7507421 |
Hydroxycitric acid salt composition and method of making
Disclosed is a hydroxycitric acid salt composition comprising calcium and potassium salts of hydroxycitric acid, preferably in a defined proportion which yields a very pure, stabilized preparation...
|
|
|
7504560 |
Vaccines expressed in plants
The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion...
|
|
|
7501274 |
Lactic acid bacteria with immunoregulating activities
The invention provides novel lactic acid bacteria having immunoregulating activities and usable in food and drinks, medicaments, and other applications. Specifically, the invention provides novel...
|
|
|
7494680 |
Fat or oil composition
Provided is a fat or oil composition containing the following components (A), (B) and (C): (A) 100 parts by weight of a fat or oil containing from 0.1 to 10 wt. % of a monoglycerol monofatty acid...
|
|
|
7491836 |
Non-ionic surfactants for poorly soluble molecules
New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene/alkyl...
|
|
|
7488494 |
Compositions and therapeutic methods involving isoflavones and analogues thereof
Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen...
|
|
|
7485743 |
Oligomeric ketone compounds
A novel keto8enic compound is provided having general: Formula R(OCH(CH 3 )CH 2 C(O)) n —O-A wherein n is an integer of 3 to 10, A is the residue of a 3-keto alkan-1-ol and R is selected from the...
|
|
|
7485325 |
Animal food supplement compositions and methods of use
An animal food supplement particularly useful in treating gastrointestinal problems, such as colic. Psyllium husks are provided in dry form for convenience of handling prior to feeding. In examples...
|
|
|
7482031 |
Development of an anti-cough, anti-tussive and throat soothing herbal formulation
An anti-cough, anti-tussive, and throat soothing synergistic herbal formulation comprising of an extract of Piper cubeba, Glycyrrhiza glabra, Acorus calamus Alpinia galanga, Zingiber officinale ...
|
|
|
7476399 |
Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor...
|
|
|
7470436 |
Water-soluble composition containing coenzyme Q10
A water-soluble composition comprising (A) coenzyme Q 10 of 5-40% by weight, (B) monoester of polyglycerol with average polymerization degree of 10 and fatty acid with 18 carbon atoms of 5-30% by...
|
|
|
7468193 |
Nutritional composition against side effects of chemotherapy or radiotherapy
The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid...
|
|
|
7452916 |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
Endothelial nitric oxide production is enhanced by administration of arginine or lysine as a dietary supplement. Enhanced nitric oxide production from arginine supplementation improves vascular...
|
|
|
7452549 |
Synergistic antioxidant combination of delta tocols and polyphenols
A source of δ-tocotrienol and/or-tocopherol acts synergistically with an antioxidant source comprising polyphenols, to effect suppression of LDL oxidation in serum. The combination of these two...
|
|
|
7452548 |
Conjugated linoleic acid compositions
Novel compositions containing conjugated linoleic acids are efficacious as animal feed additives and human dietary supplements. Linoleic acid is converted to its conjugated forms in which the...
|
|
|
7442541 |
β-glucan-containing fat and oil composition and novel microorganism capable of producing β-glucan
A β-glucan-containing fat and oil composition contains β-glucan of microorganism origin or basidiomycete origin. The β-glucan-containing fat and oil composition has β-glucan uniformly dispersed...
|
|
|
7438903 |
Methods and compositions that enhance bioavailability of coenzyme-Q10
Bioavailability of Coenzyme-Q10 (“Co-Q10”), an oil-soluble substance, can be enhanced in a subject by modifying, e.g. nanonizing or charging, the form of Co-Q10. Co-Q10 bioavailability also can...
|
|
|
7435427 |
Pharmaceutical semi-solid composition of isotretinoin
An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an...
|
|
|
7435426 |
Micron sized bicarbonate particles and slurrys containing the same
This invention provides substantially spherical, micron and submicron sized alkali metal bicarbonate particles. When combined with a liquid medium, the alkali metal bicarbonate particles have an...
|
|
|
7431939 |
Inhibition of systemic infections in humans and vertebrates by dietary fibers
The use of a dietary fiber or a mixture of dietary fibers for the manufacture of a composition, being a pharmaceutical composition or a functional food or a functional feed, for the prevention, the...
|
|
|
7429390 |
Stable pharmaceutical compositions, processes for making the same and methods of their use
The present invention is generally related to alcohol free, liquid ranitidine formulations for oral administration. In particular, the present invention is related to stable, syrup formulations...
|
|
|
7427413 |
Stable shaped particles of crystalline organic compounds
The present invention provides storage stable, shaped particles of allotropic organic compounds. The particles of the present invention can be shaped according to the desired application. Preferred...
|
|
|
7427398 |
Mammalian animal composition
The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian...
|
|
|
7422764 |
Matrix-forming composition containing pectin
A liquid edible composition with a pH of more than 6, a viscosity below 600 mPas at a shear rate of 100s-1 and 20° C., and a viscosity of at least 125% of the aforementioned viscosity at a pH...
|
|
|
7419682 |
Poultry feed containing plasma
The present invention relates to pelleted poultry feed containing plasma, and methods of making and using pelleted poultry feed containing plasma.
|
|
|
7414079 |
Utilization of rhinologically active substances
Acyclic compounds containing an ether functionality external to the ring can be used as rhinologically active substances. In the regions of the mouth, the throat and the airways they produce a...
|
|
|
7410663 |
Oil or fat composition
The present invention relates to an oil or fat composition containing the following components (A) and (B):
(A) from 80 to 99.9 wt. % of a monoglyceride containing 20 to 75 wt. % of...
|
|
|
7410653 |
Method for the production of an immunostimulant milk product and uses thereof
A method for the production of an imnmunostimulant milk product, characterized in that bioconversion is carried out on or a milk substrate with the aid of a Bifidobacterium culture by keeping...
|